Top Tech Features Behind Medication Adherence Success

The tech platform a health plan utilizes to execute its medication adherence strategy makes all the difference in that strategy’s effectiveness. Technology adds immense value, allowing clinicians to carry out more accurate and personal engagements with each consumer during outreach. Given the wide range of approaches in the market today, from pharmacists working with spreadsheets to sophisticated software, our team is launching a blog series to highlight the benefits of a comprehensive tech-enabled approach and to share the main components to look for when investing in a tech platform to manage medication adherence.

Ultimately, the goal of deploying a unified and integrated platform is to give a health plan’s case management team or contracted clinicians a single powerful tool that works with them for seamless and timely engagements tailored to the individual’s needs. Just as a client relationship management (CRM) software enables businesses to better connect with their clients over time, the right medication adherence software can enhance clinicians’ outreach to consumers who likely need more than one touchpoint to become adherent. In this post, we’ll outline the core tech capabilities needed to target the right consumers at the right time.

Risk Identification and Stratification

A good tech platform for medication adherence starts with predictive analytics capabilities to identify target populations for engagement. This technology should contain a smart workflow with a rules engine built specifically to identify clinical quality measures and proactively target consumers at risk for medication non-adherence or gaps in care. That same rules engine should then stratify those consumers for outreach based on their level of risk across medication usage, drug therapy plans and more.

An advanced rules and analytics engine includes:

  • Cloud-based execution for greater scale and security
  • Ongoing and secure data ingestion of pharmacy and medical claims data for comprehensive evaluation
  • Data reconciliation informed by daily consumer outreach for enhanced reporting of improvements and outcomes

Clinical Data Evaluation Capabilities

The workflow of risk identification goes hand in hand with the process of stratifying data against HEDIS® and other quality measures to ensure alignment with established quality improvement practices. A rules engine must be built to make clinical evaluations of data based on established quality measures used by regulatory bodies for quality assurance.

This means the technology algorithms should be set to evaluate data against any or all of the following, depending on a plan’s needs:

  • Pharmacy Quality Alliance (PQA) measures
  • Healthcare Effectiveness Data and Information Set (HEDIS®) measures
  • Medicare Advantage (MA) Part C and D measures
  • Customizable measures based on population needs

These components and capabilities work together within a smart workflow to determine next best action for outreach. Next, we’ll cover the importance of integrating intervention and pharmacy platforms into that same smart workflow to further streamline the outreach to address gaps in care and reduce costs with carve-in pharmacy services.

AdhereHealth Releases Next-Generation Resolve Offering to Improve Member Experience for CAHPS and HOS Surveys

New Adhere™ Platform capabilities support dramatic CMS Increase of Medicare Advantage CAHPS Member Experience Star Rating Weighting to 32% through

Postdischarge Medication Reconciliation Is the Key to Reducing Hospital Readmissions

Medicare Advantage plans have a clear opportunity to improve quality by delivering more comprehensive, timely medication reconciliation services to recently

AdhereHealth Launches High-Risk Patient COVID-19 Vaccine Accelerator for the Underserved

Innovative solution leverages analytics and outbound tele-pharmacy to ensure equitable access to vaccinations by engaging vulnerable populations and reducing barriers

Medically Necessary: Making the vaccine supply chain work for communities of color

Americans of color are receiving the vaccine at far lower rates than white Americans, even though people of color are

Building a Comprehensive Strategy for Medicare Advantage Star Ratings

Whether you are a health plan leader or financial executive, you’re well aware that achieving and maintaining excellent Medicare Advantage

Medication Adherence Is Key To Addressing the Social Determinants of Health During the COVID-19 Pandemic

More than a year after scientists identified the first cases of COVID-19, infection rates continue to rise in regions across

It’s the Zip Code, Not the Genetic Code—The Need for an Equitable Vaccination Strategy

There is an urgent need to accelerate vaccination distribution for vulnerable Americans by overcoming problems involving social determinants of health.

CMS 2022 Final Rules: Top 6 Things Health Plans Should Know

CMS has finalized a series of policy and technical changes to Medicare Advantage (MA) and the Medicare Prescription Drug Benefit

Implementing Pharmacy-Led Telehealth Strategies to Help Medicare Advantage SNPs Improve Care for Older Adults Amid COVID-19 and Beyond

Pharmacy-led telehealth strategies will position Special Needs Plans (SNPs) for Star Ratings success during the pandemic and for years to

Medicare Advantage Star Ratings Enhancement: The Cost of Complacency for Health Plans

Medicare Advantage (MA) Star Ratings are the most critical evaluation of MA Prescription Drug plans, standing as a designation of

How to Address SDOH and Medication Adherence to Improve Star Ratings Outcomes for Dual Special Needs Plans

The most recent data from the Centers for Medicare and Medicaid Services (CMS) estimates that across the United States, there

2021 Medicare Advantage Star Ratings Changes and CAHPS Improvement

Centers for Medicare and Medicaid Services (CMS) has announced some key changes to the Medicare Advantage (MA) Star Ratings formula